270 related articles for article (PubMed ID: 16632219)
1. New American Joint Commission on Cancer staging system for melanoma: prognostic impact and future directions.
Ross MI
Surg Oncol Clin N Am; 2006 Apr; 15(2):341-52. PubMed ID: 16632219
[TBL] [Abstract][Full Text] [Related]
2. Reflecting on the 2001 American Joint Committee on Cancer Staging System for melanoma.
Retsas S; Mastrangelo MJ
Semin Oncol; 2007 Dec; 34(6):491-7. PubMed ID: 18083372
[TBL] [Abstract][Full Text] [Related]
3. Early-stage melanoma: staging criteria and prognostic modeling.
Ross MI
Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2312s-2319s. PubMed ID: 16609051
[TBL] [Abstract][Full Text] [Related]
4. Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma.
Ben-Porat L; Panageas KS; Hanlon C; Patel A; Halpern A; Houghton AN; Coit D
Cancer; 2006 Jan; 106(1):163-71. PubMed ID: 16331596
[TBL] [Abstract][Full Text] [Related]
5. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
Gimotty PA; Elder DE; Fraker DL; Botbyl J; Sellers K; Elenitsas R; Ming ME; Schuchter L; Spitz FR; Czerniecki BJ; Guerry D
J Clin Oncol; 2007 Mar; 25(9):1129-34. PubMed ID: 17369575
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for melanoma.
Wisco OJ; Sober AJ
Dermatol Clin; 2012 Jul; 30(3):469-85. PubMed ID: 22800552
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
[TBL] [Abstract][Full Text] [Related]
8. Microstaging in cutaneous melanoma.
Ruiter DJ; Spatz A; van den Oord JJ; Cook MG;
J Pathol; 2001 Dec; 195(5):525-9. PubMed ID: 11745686
[TBL] [Abstract][Full Text] [Related]
9. [Primary cutaneous melanoma: prognostic factors not included in the classification of the American Joint Committee on Cancer].
Tejera-Vaquerizo A; Solís-García E; Ríos-Martín JJ; Moreno-Ramírez D
Actas Dermosifiliogr; 2011 May; 102(4):255-63. PubMed ID: 21440241
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in patients with localized primary cutaneous melanoma.
Mervic L
Acta Dermatovenerol Alp Pannonica Adriat; 2012; 21(2):27-31. PubMed ID: 23000937
[TBL] [Abstract][Full Text] [Related]
11. The role of microsatellites as a prognostic factor in primary malignant melanoma.
Shaikh L; Sagebiel RW; Ferreira CM; Nosrati M; Miller JR; Kashani-Sabet M
Arch Dermatol; 2005 Jun; 141(6):739-42. PubMed ID: 15967920
[TBL] [Abstract][Full Text] [Related]
12. A population-based validation of the American Joint Committee on Cancer melanoma staging system.
Gimotty PA; Botbyl J; Soong SJ; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8065-75. PubMed ID: 16258105
[TBL] [Abstract][Full Text] [Related]
13. Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly clark level, affects pathologic staging of primary cutaneous melanoma.
Murali R; Hughes MT; Fitzgerald P; Thompson JF; Scolyer RA
Ann Surg; 2009 Apr; 249(4):641-7. PubMed ID: 19300224
[TBL] [Abstract][Full Text] [Related]
14. Implications of the 2009 American Joint Committee on Cancer Melanoma Staging and Classification on dermatologists and their patients.
Nading MA; Balch CM; Sober AJ
Semin Cutan Med Surg; 2010 Sep; 29(3):142-7. PubMed ID: 21051007
[TBL] [Abstract][Full Text] [Related]
15. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
16. A rational surgical approach to the treatment of distant melanoma metastases.
Martinez SR; Young SE
Cancer Treat Rev; 2008 Nov; 34(7):614-20. PubMed ID: 18556133
[TBL] [Abstract][Full Text] [Related]
17. A single-institution validation of the AJCC staging system for stage IV melanoma.
Neuman HB; Patel A; Ishill N; Hanlon C; Brady MS; Halpern AC; Houghton A; Coit DG
Ann Surg Oncol; 2008 Jul; 15(7):2034-41. PubMed ID: 18465172
[TBL] [Abstract][Full Text] [Related]
18. Some of the 2009 American Joint Committee on Cancer melanoma staging and classification is not evidence based.
Thomas JM; Strauss DC; Hayes AJ
J Clin Oncol; 2010 Sep; 28(27):e479; author reply e480-1. PubMed ID: 20566996
[No Abstract] [Full Text] [Related]
19. Establishing prognosis in retroperitoneal sarcoma: a new histology-based paradigm.
Anaya DA; Lahat G; Wang X; Xiao L; Tuvin D; Pisters PW; Lev DC; Pollock RE
Ann Surg Oncol; 2009 Mar; 16(3):667-75. PubMed ID: 19101765
[TBL] [Abstract][Full Text] [Related]
20. Current melanoma staging.
Petro A; Schwartz J; Johnson T
Clin Dermatol; 2004; 22(3):223-7. PubMed ID: 15262308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]